Patent ID: 8415109
Filing Date: 2013-04-09
Classification: A61P,G01N

Abstract:
1. A method for diagnosing pancreatic cancer in a patient comprising isolating a pancreatic tissue sample from a patient suspected of having pancreatic cancer, contacting said pancreatic tissue sample with a binding agent capable of detecting a level of NMDA-1 glutamate receptor protein in said sample, contacting a pancreatic tissue sample known to be free of pancreatic cancer with said binding agent, comparing the levels of NMDA-1 glutamate receptor protein in the pancreatic tissue samples, and diagnosing pancreatic cancer in the patient, wherein an increase in the level of NMDA-1 glutamate receptor protein in the sample from the patient suspected of having pancreatic cancer as compared to the level detected in the pancreatic tissue sample known to be free of pancreatic cancer indicates the patient has pancreatic cancer.